Please note that this website is no longer being maintained. For all current information and registration please refer to GenQA.

Latest News

HOT OFF THE PRESS - HOT OFF THE PRESS

This letter contains important information for CEQAS Participants., please take some time to read it.

Last updated: Wednesday, 01 November 2017

Best Practice Meetings 2017

Best Practice and Reporting Guidelines are an essential step towards improvement and harmonisation of laboratory practice, nationally and internationally. CEQAS, in collaboration with experts and participants, has for many years been leading the way in facilitating the development and publication of Best Practice Guidelines.  

Last updated: Wednesday, 05 April 2017

Participants Meetings 2017

In 2017 CEQAS will be holding the following Participants' Meetings:

  • PGD Participants' Meeting - Friday, 8th December 2017, 17:15 at the Raddison Blue Hotel in Brussels. Programme available soon.
Last updated: Friday, 20 October 2017

UK NEQAS: Coordinating Point of Care Testing’ Meeting October 2017

S A V E   T H E   D A Y  -  FRIDAY, 20TH OCTOBER  -  S A V E   T H E  D A Y

 

Last updated: Wednesday, 18 January 2017

CEQAS Job Opportunities

There are currently no vacancies but watch this space.

 

Last updated: Thursday, 29 December 2016

CEQAS statement following the UK Referendum

CEQAS is an international EQA provider, operated by Oxford University Hospitals NHS Foundation Trust. CEQAS is a UKAS accredited proficiency test provider No 7872. CEQAS offers EQAs to participants worldwide. We are a non-governmental, not-for-profit organisation hosted in Oxford University Hospitals NHS Trust. CEQAS is a member of the UK NEQAS Consortium charity.

Last updated: Thursday, 29 December 2016

6th International workshop on Cancer Genetic & Cytogenetic Diagnostics, March 2018

March 28 to March 30, 2018 Radboud University Medical Center, Nijmegen, The Netherlands

Last updated: Thursday, 23 November 2017

FISH probe problems in enriched plasma cells in Myeloma

Please find below an announcement from two UK laboratories regarding common FISH problems encountered in Myeloma - specifically a false positive TP53 deletion.

Last updated: Monday, 11 January 2016
Go to top